Prostate cancer kills thousands of Americans each year but new research suggests men can drastically lower their risk ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

INDIANAPOLIS — Nearly 143,000 Hoosiers will die from cancer this year, according to data from the Indiana Department of Health and the American Cancer Society. Prostate cancer is the most commonly ...

Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments have been game-changers for lung cancer and skin cancer, prostate cancer ...

For more than two decades, Chan Soon-Shiong Institute of Molecular Medicine at Windber has kept a mission to improve patients’ care through research. That mission is now expanding to ...

Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.

At the 2026 Genitourinary Cancers Symposium in San Francisco, CA, Madan discusses a study investigating short-course (3-month ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...

The ongoing Daro-PET study set out to evaluate the ability of the oral androgen receptor inhibitor darolutamide (Nubeqa) to ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...